logo
Select company
Select metric
$ -20.34MConsolidated Income
VS
Market
28
Sector
55
Industry
68
History
-
$ 6.06Close
$ 4.93 - $ 10.19 52-Week Range
Ticker Information

Ticker

COYA

Company Name

COYA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

COYA THERAPEUTICS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

COYA - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -20.34M
3/31/2025$ -17.14M
12/31/2024$ -14.88M
9/30/2024$ -10.7M
6/30/2024$ -10.1M
3/31/2024$ -10.3M
12/31/2023$ -7.99M
9/30/2023$ -12.36M
12/31/2022$ -12.24M
12/31/2021$ -4.89M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • COYA THERAPEUTICS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -4.89M.
  • Over the past 5 years, COYA THERAPEUTICS INC's average Cons. Inc. has been $ -12.09M.
  • The median Cons. Inc. for COYA THERAPEUTICS INC during this period was $ -11.47M
  • COYA THERAPEUTICS INC reached its highest Cons. Inc. over the past 5 years at $ -4.89M.
  • The lowest Cons. Inc. recorded by COYA THERAPEUTICS INC in the same timeframe $ -20.34M

COYA THERAPEUTICS INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
AVTX : AVALO THERAPEUTICS INC $ -46.22MABVC : ABVC BIOPHARMA INC $ -3.28MVTGN : VISTAGEN THERAPEUTICS INC $ -55.78MRPTX : REPARE THERAPEUTICS INC $ -109.86MINO : INOVIO PHARMACEUTICALS INC $ -87.76MENTX : ENTERA BIO LTD $ -10.6MCOEP : COEPTIS THERAPEUTICS HOLDINGS INC $ -12.6MIBIO : IBIO INC $ -18.38MPULM : PULMATRIX INC $ -7.93MCLNN : CLENE INC $ -29.7M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

COYA - Consolidated Income, Last 5 years

$ -20.34M

Minimum

Jun 30, 2025

$ -4.89M

Maximum

Dec 31, 2021

$ -12.09M

Average

$ -11.47M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.09M with a standard deviation of $ 116.52M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.09M
median$ -2.07M
std$ 116.52M